Some commentary from Macquarie emailed yesterday, this looks to be a major issue ATM and keeping the share price well below the 4.77 high.
Emerging Leaders
Acrux ACR Underperform
Rebates remain stubbornly high
* Eli Lilly reported Axiron 4Q net sales at US$23.9m (vs. Macq at US$22.6m).
* Solid net sales number due to lower than expected rebate; however, it appears that the rebate has increased on a seasonally adjusted basis.
* Underperform. Positive that Q4 rebates were lower than Q3, but still increased on a seasonally adjusted basis and concern about slowing market growth.
- Forums
- ASX - By Stock
- rebate
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.6¢

Some commentary from Macquarie emailed yesterday, this looks to...
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.548M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 351996 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 358041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 216996 | 0.016 |
4 | 945382 | 0.015 |
3 | 391428 | 0.014 |
3 | 389550 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 358041 | 1 |
0.018 | 475000 | 2 |
0.019 | 146993 | 2 |
0.020 | 847795 | 7 |
0.021 | 122699 | 1 |
Last trade - 16.21pm 08/08/2025 (20 minute delay) ? |
ACR (ASX) Chart |
Day chart unavailable